全文获取类型
收费全文 | 199篇 |
免费 | 10篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 4篇 |
妇产科学 | 3篇 |
基础医学 | 24篇 |
口腔科学 | 1篇 |
临床医学 | 14篇 |
内科学 | 21篇 |
皮肤病学 | 4篇 |
神经病学 | 24篇 |
特种医学 | 4篇 |
外科学 | 29篇 |
预防医学 | 33篇 |
药学 | 39篇 |
肿瘤学 | 3篇 |
出版年
2023年 | 5篇 |
2021年 | 3篇 |
2020年 | 6篇 |
2019年 | 4篇 |
2018年 | 8篇 |
2017年 | 3篇 |
2016年 | 3篇 |
2015年 | 6篇 |
2014年 | 10篇 |
2013年 | 9篇 |
2012年 | 16篇 |
2011年 | 12篇 |
2010年 | 7篇 |
2009年 | 3篇 |
2008年 | 4篇 |
2007年 | 2篇 |
2006年 | 5篇 |
2005年 | 6篇 |
2004年 | 2篇 |
2003年 | 7篇 |
2002年 | 3篇 |
2001年 | 4篇 |
2000年 | 4篇 |
1998年 | 2篇 |
1995年 | 2篇 |
1991年 | 4篇 |
1990年 | 5篇 |
1989年 | 2篇 |
1988年 | 4篇 |
1987年 | 1篇 |
1986年 | 3篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1975年 | 5篇 |
1974年 | 5篇 |
1973年 | 2篇 |
1972年 | 4篇 |
1971年 | 3篇 |
1970年 | 4篇 |
1969年 | 3篇 |
1968年 | 2篇 |
1966年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有209条查询结果,搜索用时 31 毫秒
201.
This investigation is a contribution to standardization in in vitro drug penetration measurements using excised human skin and to statistical treatment of the observations. The wide variations observed in measurements of drug accumulation in and drug permeation through the stratum corneum are caused not only by analytical errors but also by the variability of the horny layer lipid composition. The last-mentioned systematic influence can be compensated for by stepwise (multiple) linear regression using the contents of the main lipid classes as independent variables. In consequence, the S.E. of estimate given by the regression calculation is lower than the S.E. of the means of the observations. Significant differences in drug quantities accumulated in skin tissues (stratum corneum and dermis) are sensitively detected by Chow's F-test of structural change. Accumulation data of flufenamic acid and hydrocortisone penetrated from different bases are given as examples. The calculation mode is exemplarily explained and discussed. The results of the test for structural change, two-independent-groups t-test and paired-samples t-test are compared. The F-test of structural change proves to be a helpful statistical method suitable to the assessment of biopharmaceutical quality parameters and to measurements using biological materials. 相似文献
202.
Thomas P White Eva Loth Katya Rubia Lydia Krabbendam Robert Whelan Tobias Banaschewski Gareth J Barker Arun LW Bokde Christian Büchel Patricia Conrod Mira Fauth-Bühler Herta Flor Vincent Frouin Jürgen Gallinat Hugh Garavan Penny Gowland Andreas Heinz Bernd Ittermann Claire Lawrence Karl Mann Marie-Laure Paillère Frauke Nees Tomas Paus Zdenka Pausova Marcella Rietschel Trevor Robbins Michael N Smolka Sukhwinder S Shergill Gunter Schumann the IMAGEN Consortium 《Neuropsychopharmacology》2014,39(11):2560-2569
Catecholamine-0-methyl-transferase (COMT) gene variation effects on prefrontal blood oxygenation-level-dependent (BOLD) activation are robust; however, despite observations that COMT is estrogenically catabolized, sex differences in its prefrontal repercussions remain unclear. Here, in a large sample of healthy adolescents stratified by sex and Val158Met genotype (n=1133), we examine BOLD responses during performance of the stop-signal task in right-hemispheric prefrontal regions fundamental to inhibitory control. A significant sex-by-genotype interaction was observed in pre-SMA during successful-inhibition trials and in both pre-SMA and inferior frontal cortex during failed-inhibition trials with Val homozygotes displaying elevated activation compared with other genotypes in males but not in females. BOLD activation in the same regions significantly mediated the relationship between COMT genotype and inhibitory proficiency as indexed by stop-signal reaction time in males alone. These sexually dimorphic effects of COMT on inhibitory brain activation have important implications for our understanding of the contrasting patterns of prefrontally governed psychopathology observed in males and females. 相似文献
203.
Lies Lahousse Bastiaan Maes Gijsbertus Ziere Daan W. Loth Vincentius J. A. Verlinden M. Carola Zillikens André G. Uitterlinden Fernando Rivadeneira Henning Tiemeier Oscar H. Franco M. Arfan Ikram Albert Hofman Guy G. Brusselle Bruno H. Stricker 《European journal of epidemiology》2014,29(6):419-427
To investigate the prevalence of frailty in a Dutch elderly population and to identify adverse health outcomes associated with the frailty phenotype independent of the comorbidities. Cross-sectional and longitudinal analyses within the Rotterdam Study (the Netherlands), a prospective population-based cohort study in persons aged ≥55 years. Frailty was defined as meeting three or more of five established criteria for frailty, evaluating nutritional status, physical activity, mobility, grip strength and exhaustion. Intermediate frailty was defined as meeting one or two frailty criteria. Comorbidities were objectively measured. Health outcomes were assessed by means of questionnaires, physical examinations and continuous follow-up through general practitioners and municipal health authorities for mortality. Of 2,833 participants (median age 74.0 years, inter quartile range 9) with sufficiently evaluated frailty criteria, 163 (5.8 %) participants were frail and 1,454 (51.3 %) intermediate frail. Frail elderly were more likely to be older and female, to have an impaired quality of life and to have fallen or to have been hospitalized. 108 (72.0 %) frail participants had ≥2 comorbidities, compared to 777 (54.4 %) intermediate frail and 522 (44.8 %) non-frail participants. Adjusted for age, sex and comorbidities, frail elderly had a significantly increased risk of dying within 3 years (HR 3.4; 95 % CI 1.9–6.4), compared to the non-frail elderly. This study in a general Dutch population of community-dwelling elderly able to perform the frailty tests, demonstrates that frailty is common and that frail elderly are at increased risk of death independent of comorbidities. 相似文献
204.
Berge Jerica M. MacLehose Richard F. Loth Katie A. Eisenberg Marla E. Fulkerson Jayne A. Neumark-Sztainer Dianne 《Journal of behavioral medicine》2015,38(1):122-135
Journal of Behavioral Medicine - This paper aims to describe the prevalence of parent-adolescent conversations about eating, physical activity and weight across sociodemographic characteristics and... 相似文献
205.
Berge JM MacLehose RF Loth KA Eisenberg ME Fulkerson JA Neumark-Sztainer D 《Appetite》2012,58(3):1128-1135
Few studies have looked at the relationship between family meals and adult weight and health behaviors. The current study investigates the association between frequency of family meals and mothers' and fathers' body mass index (BMI), dietary intake, dieting behaviors and binge eating. Data from Project F-EAT (Families and Eating and Activity in Teens) were used for the current analysis. Socio-economically and racially/ethnically diverse mothers and fathers (n=3488) of adolescents participating in a multi-level population-based study (EAT 2010) completed surveys mailed to their homes. Predicted means or probabilities were calculated for each outcome variable at each level of family meal frequency. Interactions between race/ethnicity and marital status with family meals were evaluated in all models. Overall, results indicated that having more frequent family meals was associated with increased consumption of fruits and vegetables for mothers and fathers, after adjusting for age, educational attainment, marital status and race/ethnicity. Other findings including less fast food intake for fathers and fewer dieting and binge eating behaviors for mothers were significantly associated with family meal frequency, but not consistently across all family meal categories or with BMI. Interactions by race/ethnicity and marital status were non-significant, indicating that family meals may be important for more healthful dietary intake across race and marital status. Future research should confirm findings in longitudinal analyses to identify temporality and strength of associations. 相似文献
206.
Siddharth Srivastava Mustafa Sahin Joseph D. Buxbaum Elizabeth Berry-Kravis Latha Valluripalli Soorya Audrey Thurm Jonathan A. Bernstein Afua Asante-Otoo William E. Bennett Jr Catalina Betancur Tegwyn H. Brickhouse Maria Rita Passos Bueno Maya Chopra Celanie K. Christensen Jennifer L. Cully Kira Dies Kate Friedman Brittany Gummere J. Lloyd Holder Jr Andres Jimenez-Gomez Carolyn A. Kerins Omar Khan Teresa Kohlenberg Ronald V. Lacro Lori A. Levi Tess Levy Diane Linnehan Loth Eva Baharak Moshiree Ann Neumeyer Scott M. Paul Katy Phelan Antonio Persico Robert Rapaport Curtis Rogers Jeffrey Saland Swathi Sethuram Janine Shapiro Phillip I. Tarr Kerry M. White Jordan Wickstrom Kent M. Williams Dana Winrow Brian Wishart Alexander Kolevzon 《American journal of medical genetics. Part A》2023,191(8):2015-2044
Phelan–McDermid syndrome (PMS) is a genetic condition caused by SHANK3 haploinsufficiency and characterized by a wide range of neurodevelopmental and systemic manifestations. The first practice parameters for assessment and monitoring in individuals with PMS were published in 2014; recently, knowledge about PMS has grown significantly based on data from longitudinal phenotyping studies and large-scale genotype–phenotype investigations. The objective of these updated clinical management guidelines was to: (1) reflect the latest in knowledge in PMS and (2) provide guidance for clinicians, researchers, and the general community. A taskforce was established with clinical experts in PMS and representatives from the parent community. Experts joined subgroups based on their areas of specialty, including genetics, neurology, neurodevelopment, gastroenterology, primary care, physiatry, nephrology, endocrinology, cardiology, gynecology, and dentistry. Taskforce members convened regularly between 2021 and 2022 and produced specialty-specific guidelines based on iterative feedback and discussion. Taskforce leaders then established consensus within their respective specialty group and harmonized the guidelines. The knowledge gained over the past decade allows for improved guidelines to assess and monitor individuals with PMS. Since there is limited evidence specific to PMS, intervention mostly follows general guidelines for treating individuals with developmental disorders. Significant evidence has been amassed to guide the management of comorbid neuropsychiatric conditions in PMS, albeit mainly from caregiver report and the experience of clinical experts. These updated consensus guidelines on the management of PMS represent an advance for the field and will improve care in the community. Several areas for future research are also highlighted and will contribute to subsequent updates with more refined and specific recommendations as new knowledge accumulates. 相似文献
207.
Thomas W. Frazier Robyn M. Busch Patricia Klaas Katherine Lachlan Shafali Jeste Alexander Kolevzon Eva Loth Jacqueline Harris Leslie Speer Tom Pepper Kristin Anthony J. Michael Graglia Christal G. Delagrammatikas Sandra Bedrosian-Sermone Constance Smith-Hicks Katie Huba Robert Longyear LeeAnne Green-Snyder Frederick Shic Mustafa Sahin Charis Eng Antonio Y. Hardan Mirko Uljarević 《American journal of medical genetics. Part C, Seminars in medical genetics》2023,193(3):e32058
This study focused on the development and initial psychometric evaluation of a set of online, webcam-collected, and artificial intelligence-derived patient performance measures for neurodevelopmental genetic syndromes (NDGS). Initial testing and qualitative input was used to develop four stimulus paradigms capturing social and cognitive processes, including social attention, receptive vocabulary, processing speed, and single-word reading. The paradigms were administered to a sample of 375 participants, including 163 with NDGS, 56 with idiopathic neurodevelopmental disability (NDD), and 156 neurotypical controls. Twelve measures were created from the four stimulus paradigms. Valid completion rates varied from 87 to 100% across measures, with lower but adequate completion rates in participants with intellectual disability. Adequate to excellent internal consistency reliability (α = 0.67 to 0.95) was observed across measures. Test–retest reproducibility at 1-month follow-up and stability at 4-month follow-up was fair to good (r = 0.40–0.73) for 8 of the 12 measures. All gaze-based measures showed evidence of convergent and discriminant validity with parent-report measures of other cognitive and behavioral constructs. Comparisons across NDGS groups revealed distinct patterns of social and cognitive functioning, including people with PTEN mutations showing a less impaired overall pattern and people with SYNGAP1 mutations showing more attentional, processing speed, and social processing difficulties relative to people with NFIX mutations. Webcam-collected performance measures appear to be a reliable and potentially useful method for objective characterization and monitoring of social and cognitive processes in NDGS and idiopathic NDD. Additional validation work, including more detailed convergent and discriminant validity analyses and examination of sensitivity to change, is needed to replicate and extend these observations. 相似文献
208.
Thomas W. Frazier Robyn M. Busch Patricia Klaas Katherine Lachlan Shafali Jeste Alexander Kolevzon Eva Loth Jacqueline Harris Leslie Speer Tom Pepper Kristin Anthony J. Michael Graglia Christal Delagrammatikas Sandra Bedrosian-Sermone Jenine Beekhuyzen Constance Smith-Hicks Mustafa Sahin Charis Eng Antonia Y. Hardan Mirko Uljarević 《American journal of medical genetics. Part A》2023,191(7):1741-1757
There are few well-validated measures that are appropriate for assessing the full range of neurobehavioral presentations in PTEN hamartoma tumor syndrome (PHTS) and other neurodevelopmental genetic syndromes (NDGS). As potential therapeutics are developed, having reliable, valid, free, and easily accessible measures to track a range of neurobehavioral domains will be crucial for future clinical trials. This study focused on the development and initial psychometric evaluation of a set of freely available informant-report survey scales for PHTS—the Neurobehavioral Evaluation Tool (NET). Concept elicitation, quantitative ratings, and cognitive interviewing processes were conducted with stakeholders and clinician–scientist experts, used to identify the most important neurobehavioral domains for this population, and to ensure items were appropriate for the full range of individuals with PHTS. Results of this process identified a PHTS neurobehavioral impact model with 11 domains. The final NET scales assessing these domains were administered to a sample of 384 participants (median completion time = 20.6 min), including 32 people with PHTS, 141 with other NDGS, 47 with idiopathic neurodevelopmental disorder (NDD), and 164 neurotypical controls. Initial psychometric results for the total scores of each scale indicated very good model (ω = 0.83–0.99) and internal consistency reliability (α = 0.82–0.98) as well as excellent test–retest reproducibility at 1-month follow-up (r = 0.78–0.98) and stability at 4-month follow-up (r = 0.76–0.96). Conditional reliability estimates indicated very strong measurement precision in key score ranges for assessing PHTS and other people with NDGS and/or idiopathic NDD. Comparisons across domains between PHTS and the other groups revealed specific patterns of symptoms and functioning, including lower levels of challenging behavior and more developed daily living and executive functioning skills relative to other NDGS. The NET appears to be a reliable and potentially useful tool for clinical characterization and monitoring of neurobehavioral symptoms in PHTS and may also have utility in the assessment of other NDGS and idiopathic NDD. Additional validation work, including convergent and discriminant validity analyses, are needed to replicate and extend these observations. 相似文献